<DOC>
	<DOCNO>NCT03068845</DOCNO>
	<brief_summary>The purpose randomise clinical trial evaluate efficacy drug-eluting balloon compare conventional balloon balloon-assisted maturation non-maturing arteriovenous fistula adult renal failure patient .</brief_summary>
	<brief_title>Arteriovenous Fistula : Conventional Angioplasty v Drug Eluting Balloon-assisted Maturation Intervention Clinical Trial</brief_title>
	<detailed_description>This single-centre study , total 124 subject non-maturing arteriovenous fistula randomise ( 1:1 ) either experimental active comparator arm . Randomisation stratify location arteriovenous fistula ( versus elbow ) . Each subject undergo fistulogram order ass eligibility criterion . In event 1 eligible stenosis , severe stenosis consider target ( study ) lesion . All lesion treat conventional manner . No coil embolisation collateral perform index treatment . If subject allocate experimental arm , target lesion treat pre-dilatation conventional balloon application drug-eluting ballon . If subject allocate active comparator arm , target lesion treat conventional balloon . High pressure balloon angioplasty may perform poor angioplasty result ( significant residual stenosis 30 % ) . All subject prescribe 1 month dual antiplatelets ( aspirin clopidogrel ) , follow 5 month aspirin . The duration study 12 month . Follow visit include : 1 . Two-weekly follow visit first 3 month intervention patient deem ready trial cannulation . 2 . At 3 month intervention ass primary outcome . 3 . At 6 month intervention fistulogram 4 . At 12 month intervention study closure .</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<criteria>1 . Nonmaturing upper limb arteriovenous fistula ( AVF ) create 624 week ago one following : 1 . Nonmaturing physical examination , 2 . Failed initial cannulation , 3 . Failure achieve prescribe dialysis within prescribed time frame . 2 . Stenosis ( &gt; 50 % ) along AVF circuit anastomosis , include , subclavian vein . 3 . Successful guidewire cross target lesion . 4 . &gt; = 21 year old . 5 . Informed consent give . 6 . Patient willing able return 3 month , 6 month fistulogram 12 month clinic follow . 1 . Thrombosed nonmaturing AVF 2 . Target lesion longer 8 cm 3 . Previous endovascular therapy nonmaturation trial AVF 4 . Baseline systolic blood pressure le 100 mmHg 5 . Nonmaturing AVF plan use dialysis immediate future ( e.g . chronic kidney disease require haemodialysis yet ) 6 . Coagulopathy ( prothrombin time activate partial thromboplastin time &gt; 1.5 time median normal range ) manage adequately periprocedural transfusion 7 . Thrombocytopenia ( platelet count &lt; 50,000 /Î¼L ) manage adequately periprocedural transfusion 8 . Known allergy iodinate contrast manage adequately preprocedure medication 9 . Allergy / contraindication dual antiplatelet therapy ( aspirin clopidogrel ticlopidine ) paclitaxel 10 . Acute infection propose puncture site 11 . Women breastfeed , pregnant plan become pregnant study . 12 . Men plan father child study . 13 . Participant medical condition opinion investigator may cause noncompliance protocol . 14 . Currently participate investigational drug , biologic device trial may impact AVF previous enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>non-maturing arteriovenous fistula</keyword>
	<keyword>stenosis arteriovenous fistula</keyword>
	<keyword>drug-eluting balloon</keyword>
</DOC>